Evidence map›Paper›PMID 31554573›Full record

ReviewMedical engineering & physics2019

Novel imaging approaches to screen for breast cancer: Recent advances and future prospects.

Christopher L Vaughan

Open access · greenAbstract readReview
In one paragraph

Review in Medical engineering & physics, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
2.4field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 25 citations in OpenAlex.

  1. Deep learning in multi-modal breast cancer data fusion: a literature review.Quantitative imaging in medicine and surgery · 2025
    Review
  2. Article
  3. Article
  4. Breast Imaging Physics in Mammography (Part II).Diagnostics (Basel, Switzerland) · 2023
    Review
  5. Article
  6. Actuated Reflector-Based 3-D Ultrasound Imaging With Synthetic Aperture Focusing.IEEE transactions on ultrasonics, ferroelectrics, and frequency control · 2022
    Article
  7. Review
  8. Article
  9. Breast cancer screening programs: does one risk fit all?Quantitative imaging in medicine and surgery · 2020
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

1 author at 1 institution in 1 country.

Christopher L VaughanMedical Imaging Research Unit, Faculty of Health Sciences, University of Cape Town, Observatory, Western Cape 7925, South Africa; CapeRay Medical (Pty) Ltd, Suite 2, 51 Bell Crescent, Westlake Business Park, Cape Town, Western Cape 7945, South Africa. Electronic address: kit.vaughan@uct.ac.za.
University of Cape Town · ZA

Funding

Low dose digital X-rays for mammographic screeningR21CA101705 · NCI · UNIVERSITY OF CAPE TOWN · PI VAUGHAN, CHRISTOPHER L · 2005 to 2006
$235k
NCI NIH HHS R21 CA101705
6 · The paper itself

Abstract

aim of the studyOver the past 50 years, the application of mammography - an X-ray of the breast - to screen healthy women has been a successful strategy to reduce breast cancer mortality. The aim of this study was to review the literature on novel imaging approaches that have the potential to replace mammography.

methodsAn online literature search was carried out using PubMed, Google Scholar, ScienceDirect and Google Patents. The search keywords included "breast cancer", "imaging" and "screening", with 51 journal articles and five United States patents being selected for review. Seventeen relevant online sources were also identified and referenced.

resultsIn addition to full-field digital mammography (FFDM), a further nine imaging modalities were identified for review. These included: digital breast tomosynthesis (DBT); breast computed tomography (BCT); automated breast ultrasound (ABUS); fusion of FFDM and ABUS; fusion of DBT and ABUS; magnetic resonance imaging (MRI); optical imaging; radio-wave imaging; and tactile sensor imaging. Important parameters were considered: diagnostic success (sensitivity and specificity), especially in dense breasts; time to acquire the images; and capital cost of the equipment.

conclusionsDBT is rapidly replacing FFDM although it still misses invasive cancers in dense tissue. The fusion of ABUS, either with FFDM or DBT, will lead to sensitivity and specificity approaching 100%. The fusion of opto-acoustic imaging with ultrasound holds considerable promise for the future.

Indexed as

Breast NeoplasmsDiagnostic ImagingHumansImage Processing, Computer-AssistedMass ScreeningBreast cancerDense breast tissueImagingScreening

Identifiers

PMID31554573
PMCPMC6764602
OpenAlexW2974670474

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.